Close Menu

More articles about Infectious Disease

The C. difficile test is the first molecular diagnostic product for Meridian. It hopes to market the test later this year.

The kit, which can detect Salmonella within 18 hours, was validated for use with 11 different food sample types.

Life Tech said that validation of its Applied Biosystems MicroSEQ Salmonella spp. detection kit is expected to help ensure food safety through more effective monitoring of food supply for Salmonella contamination.

The Verigene SP respiratory virus panel is the first of Nanosphere's test to get the moderate complexity designation.

The technology may enable a very stable diagnostic method to detect nucleic acids without using PCR, and has so far been demonstrated to detect anthrax.

Kettering Health Network hopes to cut costs by using Diatherix's PCR-based infectious disease tests.

Enzo plans to seek approval for and market MultiGen's antenatal infectious disease tests in New York and in other US regions.

Under the new license with Roche, Biosearch now has the right to manufacture and sell validated kits, including probes, primers, enzymes, and other essential nucleic acid amplification technologies.

Duke University researchers have identified gene expression signatures in mice that are linked to Candida albicans bloodstream infections and can discern between these fungal infections and those caused by bacteria.

Although the collaboration is aimed at increasing physician knowledge of genomic testing associated with all HIV drugs, it appears to have stemmed from lower-than-expected sales of Pfizer's CCR5-antagonist Selzentry.

The newest deal will focus on miRNA-122, with hepatitis C infection as the initial indication.

Alnylam previously released data from a phase IIa study of the drug in RSV-infected adult lung transplant patients showing that it was safe and well tolerated. While the data indicated a certain level of efficacy, this demonstration was less robust than many industry watchers had expected.

Longhorn wins FDA EUA for H1N1 flu test; UC-Davis offering RT-PCR respiratory viral panel test.

The San Antonio-based firm also intends to file a 510(k) for clearance of the assay.

Researchers from Wisconsin's Wheaton Franciscan Healthcare and the University of Wisconsin have modified Becton Dickinson's GeneOhm StaphSR assay protocol in order to lower the cost of conducting active surveillance for MRSA.

Enigma struck the alliance with Tecan in anticipation of a fourth-quarter commercial launch of its miniaturized PCR instrument for point-of-care influenza diagnostic tests in Europe in partnership with GlaxoSmithKline.

The suit seeks to compel Qiagen to arbitrate a dispute related to a licensing deal Abbott had in place with Viropath and Digene, which Qiagen acquired in 2007.

Abbott wants the court to compel Qiagen to participate in arbitration over a licensing deal covering HPV IP.

Cepheid also recently inked sole-source agreements with two separate entities to conduct surveillance of methicillin-resistant Staphylococcus aureus using its GeneXpert platform, company officials said last week.

ViraCor granted FDA EMA for H1N1 flu test; University of Kentucky offering H3N8 equine flu diagnostic.

Pages

The Washington Post writes that the approval in the US of a SARS-CoV-2 vaccine will be up to Peter Marks, a career official at the Food and Drug Administration.

According to ScienceInsider, the US National Academies of Science, Engineering, and Medicine is planning a study of racism in academic research.

NPR reports the US loan to Eastman Kodak to boost domestic pharmaceutical production is on pause following insider trading allegations.

In Cell this week: blood immune cell changes in COVID-19 patients and spatial transcriptomics in Alzheimer's disease.